US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed
Friday, 15 February 2013
AstraZeneca today announced that, on 14 February 2013, the
United States Court of Appeals for the Federal Circuit summarily
upheld a lower court ruling that had found the formulation patent
protecting SEROQUEL XR (quetiapine...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news